Synapse - Kristine Peregrino Lacuna

Kristine Peregrino Lacuna

Research Focus

Medicine; Assistant Attending L1

Recent additions – View all

Phase 3 randomized controlled trial of androgen deprivation therapy with or without docetaxel in high-risk biochemically recurrent prostate cancer after surgery (TAX3503)
Journal Article

Morris, M. J.; Mota, J. M.; Lacuna, K.; Hilden, P.; Gleave, M.; Carducci, M. A.; Saad, F.; Cohn, E. D.; Filipenko, J.; Heller, G.; more...
European Urology Oncology (2021)

Fulltext@MSK | Save
A randomized, open label, multicenter, phase 3, 2-arm study of androgen deprivation with leuprolide (L), +/- docetaxel (D) for clinically asymptomatic prostate cancer (PC) subjects with a rising PSA following definitive local therapy: Safety results
Meeting Abstract

Morris, M. J.; Gleave, M. E.; Armstrong, A. J.; Carducci, M. A.; Saad, F.; Lacuna, K. P.; Scher, H. I.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save
Sera cytokine levels to predict survival in men with progressive castration-resistant prostate cancer
Meeting Abstract

Subudhi, S. K.; Heller, G.; Danila, D. C.; Anand, A.; Lacuna, K. P.; Samoila, A.; Fleisher, M.; Scher, H. I.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Co-authors at MSK

4

Scher
3

Morris
2

Heller
1

Anand
1

Carrasq...
1

Danila
1

Dayan
1

Fleisher
1

Hilden
1

Humm
1

Larson
1

Mota
1

O'Donoghue
1

Pandit-...
1

Rathkopf
1

Samoila
1

Slovin
1

Subudhi
1

Williamson

Types of Work

Publications